Submission Details
| 510(k) Number | K240558 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 28, 2024 |
| Decision Date | July 22, 2024 |
| Days to Decision | 145 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K240558 is an FDA 510(k) clearance for the NAVOYCDS, a Multivariate Vital Signs Index (Class II — Special Controls, product code PLB), submitted by Algodx AB (Stockholm, SE). The FDA issued a Cleared decision on July 22, 2024, 145 days after receiving the submission on February 28, 2024. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.2300.
| 510(k) Number | K240558 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 28, 2024 |
| Decision Date | July 22, 2024 |
| Days to Decision | 145 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | PLB — Multivariate Vital Signs Index |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.2300 |
| Definition | Automated Calculation Of A Summary Index (or Indices) Based On Several Individual Measured Vital Sign Inputs. |